Éditeur(s) : HAL CCSD Elsevier
Résumé : International audience
ISSN: 0003-4975

hal-01563338
http://hal.univ-brest.fr/hal-01563338
DOI : 10.1016/j.athoracsur.2016.03.093
PUBMED : 27262916

Résumé : Shelled molluscs are comprised of bivalves and gastropods. They are settled mainly on the continental shelf as benthic and sedentary animals due to their heavy protective shell. They can stand a wide range of environmental conditions. They are found in the whole trophic chain and are particle feeders, herbivorous, carnivorous, and predators. Exploited mollusc species are numerous. The main groups of gastropods are the whelks, conchs, abalones, tops, and turbans; and those of bivalve species are oysters, mussels, scallops, and clams. They are mainly used for food, but also for ornamental purposes, in shellcraft industries and jewelery. Consumed species are produced by fisheries and aquaculture, the latter representing 75% of the total 11.4 millions metric tons landed worldwide in 1996. Aquaculture, which mainly concerns bivalves (oysters, scallops, and mussels) relies on the simple techniques of producing juveniles, natural spat collection, and hatchery, and the fact that many species are planktivores.
Fisheries and aquaculture. Encyclopedia of life support systems : Volume II ; edited by Patrick Safran

Droits : Encyclopedia of Life Support Systems (EOLSS)
http://archimer.ifremer.fr/doc/2001/publication-529.pdf
http://archimer.ifremer.fr/doc/00000/529/

Éditeur(s) : HAL CCSD Elsevier
Résumé : International audience
Aims: The aims of this study were to compare short-and long-term outcomes for clinical T2N0 oesophageal cancer with analysis of (i) primary surgery (S) versus neoadjuvant therapy plus surgery (NS), (ii) squamous cell carcinoma and adenocarcinoma subsets; and (iii) neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy.Methods: Data were collected from 30 European centres from 2000 to 2010. Among 2944 included patients, 355 patients (12.1%) had cT2N0 disease; 285 (S) and 70 (NS), were compared in terms of short-and long-term outcomes. Propensity score matching analyses were used to compensate for differences in baseline characteristics.Results: No significant differences between the groups were shown in terms of in hospital morbidity and mortality. Nodal disease was observed in 50% of S-group at the time of surgery, with 20% pN2/N3. Utilisation of neoadjuvant therapy was associated with significant tumour downstaging as reflected by increases in pT0, pN0 and pTNM stage 0 disease, this effect was further enhanced with neoadjuvant chemoradiotherapy. After adjustment on propensity score and confounding factors, for all patients and subset analysis of squamous cell and adenocarcinoma, neoadjuvant therapy had no significant effect upon survival or recurrence (overall, loco-regional, distant or mixed) compared to surgery alone. There were no significant differences between neoadjuvant chemotherapy and chemoradiotherapy in short-or long-term outcomes.Conclusion: The results of this study suggest that a surgery alone treatment approach should be recommended as the primary treatment approach for cT2N0 oesophageal cancer despite 50% of patients having nodal disease at the time of surgery.
ISSN: 0959-8049

hal-01666517
https://hal.univ-lorraine.fr/hal-01666517
DOI : 10.1016/j.ejca.2015.11.024

Éditeur(s) : HAL CCSD Landes Bioscience
Résumé : International audience
In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. A key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process vs. those that measure flux through the autophagy pathway (i.e., the complete process); thus, a block in macroautophagy that results in autophagosome accumulation needs to be differentiated from stimuli that result in increased autophagic activity, defined as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (in most higher eukaryotes and some protists such as Dictyostelium) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the field understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field.
Autophagy

hal-00735751
https://hal.archives-ouvertes.fr/hal-00735751
PUBMED : 22966490

Éditeur(s) : 3e Rencontres Scientifiques Internationales du contrat de baie de la rade de Brest. Brest 14-16 mars 1995
Résumé : Aquaculture production of scallop has been identified by a series of technical operations during the past ten years programme under a partnership involving the fishermen organizations with regional and national grants. 3 million juveniles have been produced annually, giving a potential recapture by fishing of 100 to 120 tonnes 3 years later. Results in terms of technical and economical approach have pointed out the principal unknown factors responsable for high costs. 7he pilot programme aims to increase the production to reach a level of 5 million juveniles to support the fishery of the rade de Brest and induce new management of the resources. Two priorities were selected, control of the reproduction in the hatchery to obtain reliable larval and postlarval rearing during a larger period of the year, mainly during summer, and improvement of survival rate of the juveniles by minimizing stress when manipulating the animals. But biological and ecological mechanisms are still poorly understoodfor scallop and generally bibvalves and the last two years have shown unchanged results. The technical pathways shows interactions between the different steps of the production of juveniles where different teams operate separately. Management of the livestock has to be developed to increase the survival rate by better breeding but also to reduce the loss by adapted and coordinated practices. Recapture results indicate that fishery strategies depend also on the production of juvenile, and could orientate the management of the hatchery.

Droits : info:eu-repo/semantics/openAccess
http://archimer.ifremer.fr/doc/00044/15494/12860.pdf
http://archimer.ifremer.fr/doc/00044/15494/

Éditeur(s) : HAL CCSD American Medical Association (AMA)
Résumé : International audience
IMPORTANCE Although frequently used in treating intensive care unit (ICU) patients with sepsis, empirical antifungal therapy, initiated for suspected fungal infection, has not been shown to improve outcome. OBJECTIVE To determine whether empirical micafungin reduces invasive fungal infection (IFI)-free survival at day 28. DESIGN, SETTING, AND PARTICIPANTS Multicenter double-blind placebo-controlled study of 260 nonneutropenic, nontransplanted, critically ill patients with ICU-acquired sepsis, multiple Candida colonization, multiple organ failure, exposed to broad-spectrum antibacterial agents, and enrolled between July 2012 and February 2015 in 19 French ICUs. INTERVENTIONS Empirical treatment with micafungin (100mg, once daily, for 14 days) (n = 131) vs placebo (n = 129). MAIN OUTCOMES AND MEASURES The primary end pointwas survival without proven IFI 28 days after randomization. Key secondary end points included new proven fungal infections, survival at day 28 and day 90, organ failure, serum (1-3)-beta-D-glucan level evolution, and incidence of ventilator-associated bacterial pneumonia. RESULTS Among 260 patients (mean age 63 years; 91 [35%] women), 251 (128, micafungin group; 123, placebo group) were included in the modified intent-to-treat analysis. Median values were 8 for Sequential Organ Failure Assessment (SOFA) score, 3 for number of Candida-colonized sites, and 99 pg/mL for level of (1-3)-beta-D-glucan. On day 28, there were 82 (68%) patients in the micafungin group vs 79 (60.2%) in the placebo group who were alive and IFI free (hazard ratio [HR], 1.35 [95% CI, 0.87-2.08]). Results were similar among patients with a (1-3)-beta-D-glucan level of greater than 80 pg/mL (n = 175; HR, 1.41 [95% CI, 0.85-2.33]). Day-28 IFI-free survival in patients with a high SOFA score (> 8) was not significantly different when compared between the micafungin vs placebo groups (HR, 1.69 [95% CI, 0.96-2.94]). Use of empirical micafungin decreased the rate of new invasive fungal infection in 4 of 128 patients (3%) in the micafungin group vs placebo (15/123 patients [12%]) (P =.008). CONCLUSIONS AND RELEVANCE Among nonneutropenic critically ill patients with ICU-acquired sepsis, Candida species colonization at multiple sites, and multiple organ failure, empirical treatment with micafungin, compared with placebo, did not increase fungal infection-free survival at day 28.
ISSN: 0098-7484

hal-01405822
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01405822
DOI : 10.1001/jama.2016.14655
PUBMED : 27706483

Éditeur(s) : HAL CCSD Oxford University Press (OUP)
Résumé : International audience
ISSN: 0305-7453

hal-01470808
https://hal.archives-ouvertes.fr/hal-01470808
DOI : 10.1093/jac/dkw352
PUBMED : 27609051

Éditeur(s) : ICCAT, Madrid (Spain)
Résumé : Cette étude intègre simultanément les données de la pêcherie palangrière de l'Atlantique Nord Central (prises annuelles en nombre par classes d'âge à partir des échantillonnages de la pêcherie japonaise) et les données de la pêcherie de surface franco-espagnole de l'Atlantique Nord-Est (prises annuelles en nombre par classes d'âge à partir des échantillonnages de la pêcherie française). L'analyse des cohortes sur ces données conduit à des estimations de Fi et de tailles de cohortes au recrutement et la sortie de la pêche de surface, puis au recrutement de la pêcherie palangrière. Le recoupement et le recouvrement de ces résultats permettent de construire une série de Fi et, à partir des données de Mi extraites d'autres études, d'appliquer les modèles classiques de rendement pondéral par recrue. L'analyse est menée parallèlement sur le rendement pondéral par recrue et la fécondité du stock. Le développement et l'emploi de modèles et programmes originaux de gestion tenant des divers techniques et engins de pêche (multi-arts de pêche, "multi-gear") permettent de tirer des conclusions sur les effets respectifs des deux pêcheries : palangre sur les adultes et surface sur les jeunes. [OCR NON CONTRÔLE]
ICCAT/CICTA Recueil de Documents Scientifiques (ICCAT, Madrid (Spain)), 1974 , Vol. 4 , P. 619-651

Droits : ICCAT, Madrid (Spain)
http://archimer.ifremer.fr/doc/1974/publication-5469.pdf
http://archimer.ifremer.fr/doc/00000/5469/